RBC-SCAN Drug Patent Profile
✉ Email this page to a colleague
When do Rbc-scan patents expire, and when can generic versions of Rbc-scan launch?
Rbc-scan is a drug marketed by Cadema and is included in one NDA.
The generic ingredient in RBC-SCAN is technetium tc-99m red blood cell kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m red blood cell kit profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RBC-SCAN?
- What are the global sales for RBC-SCAN?
- What is Average Wholesale Price for RBC-SCAN?
Summary for RBC-SCAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | RBC-SCAN at DailyMed |
US Patents and Regulatory Information for RBC-SCAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadema | RBC-SCAN | technetium tc-99m red blood cell kit | INJECTABLE;INJECTION | 020063-001 | Jun 11, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
